Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Annals of Clinical and Translational Neurology|October 31, 2014
Immunomodulatory activity of interferon-betaLloyd H Kasper, Anthony T Reder
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 19, 2021
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?Daniel B Horton, Anthony T Reder
Current Opinion in Ophthalmology|October 8, 2009
Multiple sclerosis. Part I: neuro-ophthalmic manifestationsJohn H Pula, Anthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2012
Response to GS Gronseth and E AshmanDouglas S Goodin, Anthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2012
Evidence-based medicine: promise and pitfallsDouglas S Goodin, Anthony T Reder
Multiple Sclerosis and Related Disorders|December 7, 2016
Corrigendum to 'Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature' [Mult. Scler. Relat. Disord. 9 (2016) 158-162]Elena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Multiple Sclerosis and Related Disorders|September 21, 2016
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literatureElena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Neurology and Therapy|December 16, 2017
Vitamin D and Multiple Sclerosis: A Comprehensive ReviewMartina B Sintzel, Mark Rametta, Anthony T Reder
JAMA|October 25, 2012
Treatment with interferon beta for multiple sclerosisDouglas S Goodin, Anthony T Reder, Gary Cutter
Neurology|March 25, 2009
4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitisAamir Badruddin, Ravi S Menon, Anthony T Reder
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Annals of Clinical and Translational Neurology|October 31, 2014
Immunomodulatory activity of interferon-betaLloyd H Kasper, Anthony T Reder
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 19, 2021
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?Daniel B Horton, Anthony T Reder
Current Opinion in Ophthalmology|October 8, 2009
Multiple sclerosis. Part I: neuro-ophthalmic manifestationsJohn H Pula, Anthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2012
Response to GS Gronseth and E AshmanDouglas S Goodin, Anthony T Reder
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2012
Evidence-based medicine: promise and pitfallsDouglas S Goodin, Anthony T Reder
Multiple Sclerosis and Related Disorders|December 7, 2016
Corrigendum to 'Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature' [Mult. Scler. Relat. Disord. 9 (2016) 158-162]Elena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Multiple Sclerosis and Related Disorders|September 21, 2016
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literatureElena Grebenciucova, Anthony T Reder, Jacqueline T Bernard
Neurology and Therapy|December 16, 2017
Vitamin D and Multiple Sclerosis: A Comprehensive ReviewMartina B Sintzel, Mark Rametta, Anthony T Reder
JAMA|October 25, 2012
Treatment with interferon beta for multiple sclerosisDouglas S Goodin, Anthony T Reder, Gary Cutter
Neurology|March 25, 2009
4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitisAamir Badruddin, Ravi S Menon, Anthony T Reder
Pageof 9